Medical Advisory Board Francois M. Blaudeau, MD Scott Carol, MD Alexander Duncan , MD Michael Johns, MD Joep Lange , MD Bruce Polsky , MD Mark C. Rogers, M.D., M.B.A. William B. Saye, MD Raymond Shinazi, Ph.D. Jean-Pierre Sommadossi, Pharm.D., Ph.D. William C. Taylor

Medical Industry Advisory Board and Scientific Advisory Board

Biomedical’s Medical Industry Advisory Board and Scientific Advisory Board were established to counsel the Board of Directors as to scientific matters that may involve the company’s proposed products. In addition to the directors and officers listed on the Organizational Chart, members include:

Francois Blaudeau, M.D. – Chairman, Scientific Advisory Board
Francois Blaudeau, M.D. Chairman of the Scientific Advisory Board. Dr. Blaudeau is currently in private practice in Obstetrics and Gynecology in Birmingham Alabama with hospital privileges at Brookwood Medical Center and Shelby Memorial Medical Center. In 1995, Dr. Blaudeau founded Lifetime Wellness, Inc., a wellness company. Dr. Blaudeau received his Bachelor of Arts degree from Birmingham Southern College in 1981 and his M.D. degree from the University of Alabama School of Medicine from July 1987 through 1991. Dr. Blaudeau received written board certification in 1993. Dr. Blaudeau recently received his J.D. degree from Birmingham School of Law (1998). He is a member of the American College of OB/GYN, the American College of Legal Medicine, Jefferson County Medical Society, Alabama Medical Association and the Alabama Quality Assurance Foundation. [ Top of page ]

Scott Carol, MD – Medical Industry Advisory Board
Scott Carol, M.D. is in private practice with the Atlanta Allergy and Asthma Clinic in Atlanta, Ga.. He is a past President of the Georgia Allergy and Immunology Society, The John Sheldon University of Michigan Allergy Society, and the Notre Dame Alumni Association of Georgia. Dr. Carroll received his B.S. from the University of Notre Dame, and his M.D. from St. Louis University, St Louis Missouri. He served his internship and residency at Glennon Children's Hospital in St. Louis. After two years service in the U.S. Air Force, he completed his fellowship at the University of Michigan in Allergy and Immunology. Dr. Carroll has published numerous articles, papers and books on allergies and immunology.

Alexander Duncan, MD – Medical Industry Advisory Board
Alexander Duncan, M.D. is assistant professor of pathology at Emory University School of Medicine in Atlanta. He also serves as medical director of the Pathology Emory Reference Laboratory (PERL) of the Emory University System of Health Care in Decatur, GA., as a director of the Hematology Laboratory at Emory University Hospital, and as Laboratory Director for Emory Adventist Hospital. Dr. Duncan received his BS from Napier College in Edinburgh, Scotland, and his MB, ChB from the University of Glasgow, Scotland. His residency in internal medicine was done at the Mayo Clinic in Rochester, Minnesota. Dr. Duncan has authored numerous publications., books and abstracts, and has lectured all over the United States as an expert in hematology and coagulation.

Michael Johns, MD – Medical Industry Advisory Board
Michael Johns, M.D. has led Emory University's widespread academic and clinical institutions and programs in the health sciences since July 1996. He oversees the School of Medicine, the Nell Hodgson Woodruff School of Nursing, the Rollins School of Public Health, the Yerkes Primate Research Center, The Emory Clinic, and more than 18 primary care centers. He also oversees Emory's long-standing patient care, teaching, and research affiliations with Grady Memorial Hospital and the Veterans Affairs Medical Center and the EMORY HEALTHCARE hospital affiliation program with 60 hospitals in Georgia and surrounding states. He is Chairman of the Board of EHCA, LLC, a limited liability company overseen by a board jointly governed by Emory Healthcare and Columbia/HCA Corporation through which Emory is responsible for clinical performance improvement and quality assurance in eight local hospitals and five surgery centers owned by Columbia/HCA. From 1990 to 1996, Dr. Johns was dean of Johns Hopkins School of Medicine and Vice President for medical Affairs at Johns Hopkins University. Dr. Johns received his bachelor's degree and continued with graduate studies in biology at Wayne State University in his hometown of Detroit. In 1969 he graduated with distinction from the University of Michigan Medical School.

Joep Lange, MD – Medical Industry Advisory Board
Joep Lange, M.D. is Director of the National Aids Therapy Evaluation Center at the University of Amsterdam in the Netherlands. A graduate of that University, he is the former Director of the National AIDS Therapy Evaluation Centre, in the Netherlands, as well as former Chief, Clinical Research and Drug Development, Global Program on AIDS for the World Health Organization. Dr. Lange has served on various advisory boards for pharmaceutical companies, on several Data and Safety Monitoring Boards for antiviral drug trials, and on several NIH review panels. He is a member of the ACTG International Virology Committee, and was a member of the Executive Committee that drafted the US Public Health Service Task Force Recommendations on the Use of Zidovudine to Reduce Perinatal Transmission of HIV. He is the author of more than 100 papers on the serology natural history and treatment of HIV infection.

Bruce Polsky, MD – Medical Industry Advisory Board
Bruce Polsky, M.D., is Chief of the Division of Infectious Diseased and Medical Director of the Virology Laboratory at St. Luke's-Roosevelt Hospital Center in New York City. A native of Michigan, Dr. Polsky is a graduate of the University of Michigan and the Wayne State University School of Medicine. His post-graduate training in Internal Medicine was at Montefiore Medical Center and the Albert Einstein College of Medicine in New York City, followed by a fellowship in infectious diseases at Memorial Sloan-Kettering Cancer Center and Cornell University Medical College, where he joined the faculty upon completion of his training in 1983, remaining until 1998. Dr. Polsky had been active in clinical investigations into HIV and other viral infections complicating neoplastic disease and AIDS since the early 1980's. HE has served on numerous national and international advisory committees, has published extensively on antiviral chemotherapy and on infectious complications of neoplastic disease and AIDS.

Mark C. Rogers, M.D., M.B.A., is presently President of Paramount Capital Corporation, a New York based investment and merchant banking firm specializing in the pharmaceutical industry. Dr. Rogers joined Paramount in June of this year. From May 1996 to May 1998, he has served as the head of strategic planning and business development for Perkin-Elmer, a Connecticut-based maker of gene-sequencing systems and other analytical and research instruments. Prior to May of 1996, Dr. Rogers was Vice Chancellor for Health Affairs of Duke University Medical Center and Executive Director and Chief Executive Officer of Duke Hospital and Health Network. Dr. Rogers was responsible for the overall administration of Duke Hospital, a 1,124 bed teaching facility located in Durham, North Carolina. Dr. Rogers joined Duke University in 1993, after 15 years at Johns Hopkins University, where he held a number of senior positions, including Distinguished Faculty Professor and Chairman of the Department of Anesthesiology and Critical Care Medicine, Associate Dean for Clinical Practice, Director of the Pediatric Intensive Care Unit, and Professor of Pediatrics. Dr. Rogers received his undergraduate degree from Columbia University and his medical degree from Upstate Medical Center in New York. Additionally, he earned his Masters in Business Administration from the Wharton School of the University of Pennsylvania. He also completed a Pediatric Fellowship at Children's Hospital Medical Center in Boston, a Cardiology Fellowship at Duke University Medical Center and an Anesthesiology Fellowship at Massachusetts General Hospital in Boston. Dr. Rogers has authored over 150 papers and 9 books and has lectured around the world as an expert in intensive care of children. In addition to his academic activities, Dr. Rogers has been involved as a founder for a number of biomedical companies and serves on the board of directors of a number of public companies in the field of health care. Dr. Rogers has been a member of the Board of Directors since 1995. [ Top of page ]

William B. Saye, MD – Medical Industry Advisory Board
William B. Saye, M.D., is founder, Medical Director and CEO of the Advanced Laparoscopy Training Center (ALTC) in Marietta, Georgia. A leading expert in Laparoscopic surgery, Dr. Saye's pioneering expertise in Laparoscopy has lead to procedural breakthroughs in cholecystectomy, hysterectomy, pelvic floor reconstruction, herniorrhaphy, cardiac and others. He is widely published in the field of Laparoscopic surgery. Approximately 14,000 surgeons have completed courses in advanced Laparoscopic techniques at ALTC since it opened in 1990.

Raymond Shinazi, Ph.D. – Medical Industry Advisory Board
Raymond Shinazi, Ph.D., is Research Scientist, V.A. Medical Center, Decatur, GA., Affiliate Scientist, Division of Pathobiology and Immunobiology, Emory University Yerkes Primate Research Center, and Professor and Director of the Laboratory of Biochemical Pharmacology, Emory University School of Medicine. Dr. Schinazi received undergraduate and Ph. D. degrees from the University of Bath, England, and completed postdoctoral work in Pharmacology and Virology/Immunology at Yale University and at Emory. Dr. Schinazi has served on numerous editorial boards over the years, and has participated in many NIH Study Sessions and Research Review groups, including Pediatric AIDS Clinical Trials GroupCore Lab, and NIH Study Sessions, (Virology Cores). He has served on the Presidential Commission on AIDS/Office of AIDS Research (Task Force on Therapeutics, and the VA AIDS Task Force/Central Office. Dr. Schinazi has published more than 260 articles and papers throughout his career.

Jean-Pierre Sommadossi, Pharm.D., Ph.D. – Medical Industry Advisory Board
Jean-Pierre Sommadossi, Pharm.D., Ph.D. , Associate Director for Basic Research,Senior Scientist Liver Center, and Associate Director, Center for AIDS Research at the University of Alabama at Birmingham. He is also Adjunct Professor at the Center for Drug Developement and Discovery, at the University of Georgia. Dr. Sommadossi is a graduate of the Faculty of Pharmacy, Marseilles, France.His postdoctoral work was done under the US-France Cancer Program Medical College of Virginia at Richmond. Currently he is a member of the Comprehensive Cancer Center Scientific Advisory Committee at the University of Alabama, Birmingham, as well as a member of the Executive Committee, Center for Aids Research there. Dr. Sommadossi has served on numerous NIH/National Research Committees, served as a consultant to major international drug companies, and has published extensively.

William C. Taylor – Medical Industry Advisory Board
William C. Taylor is currently Vice President and General Manger of Gainor Medical, the Medical Device (Microsampling) Division of Matria Healthcare. He has been in various positions with Gainor Medical since 1994, starting as Manager of R&D, Q.A. & Regulatory Affairs and progressing to Director of Product Technology and then to General Manager. From 1987-1994, Taylor held various engineering and project management positions in the Diagnostics Division of Miles (now BAYER Corporation) where his responsibilities included project management of finger lancing devices, safety lancets, and mechanical engineering of blood glucose meters. His design efforts have led to six patents and one patent pending. William joined Biomed's Scientific Advisory Board in February of 2000.

[ The Company | Organization Chart | Board of Directors | Advisory Boards ]